These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 17484283

  • 21. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
    Mutalik S, Anju P, Manoj K, Usha AN.
    Int J Pharm; 2008 Feb 28; 350(1-2):279-90. PubMed ID: 17945447
    [Abstract] [Full Text] [Related]

  • 22. Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.
    Szabó P, Sebe I, Stiedl B, Kállai-Szabó B, Zelkó R.
    J Pharm Biomed Anal; 2015 Nov 10; 115():359-67. PubMed ID: 26280924
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Original research paper. A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process.
    Pan H, Wang HB, Yu YB, Cheng BC, Wang XY, Li Y.
    Acta Pharm; 2017 Mar 01; 67(1):85-97. PubMed ID: 28231046
    [Abstract] [Full Text] [Related]

  • 25. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C, Prabhakar B.
    Drug Dev Ind Pharm; 2015 Mar 01; 41(10):1589-607. PubMed ID: 25350555
    [Abstract] [Full Text] [Related]

  • 26. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies.
    Muatlik S, Usha AN, Reddy MS, Ranjith AK, Pandey S.
    Pak J Pharm Sci; 2007 Jul 01; 20(3):218-26. PubMed ID: 17545107
    [Abstract] [Full Text] [Related]

  • 27. Effects of the host cavity size and the preparation method on the physicochemical properties of ibuproxam-cyclodextrin systems.
    Mura P, Adragna E, Rabasco AM, Moyano JR, Pérez-Martìnez JI, Arias MJ, Ginés JM.
    Drug Dev Ind Pharm; 1999 Mar 01; 25(3):279-87. PubMed ID: 10071820
    [Abstract] [Full Text] [Related]

  • 28. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
    Williams RO, Mahaguna V, Sriwongjanya M.
    Eur J Pharm Biopharm; 1998 Nov 01; 46(3):355-60. PubMed ID: 9885309
    [Abstract] [Full Text] [Related]

  • 29. Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.
    Vadher AH, Parikh JR, Parikh RH, Solanki AB.
    AAPS PharmSciTech; 2009 Nov 01; 10(2):606-14. PubMed ID: 19444620
    [Abstract] [Full Text] [Related]

  • 30. Solid-state characterization and in vitro dissolution behavior of lorazepam: Hydroxypropyl-β-cyclodextrin inclusion complex.
    Patel R, Patel M.
    Drug Discov Ther; 2010 Dec 01; 4(6):442-52. PubMed ID: 22491310
    [Abstract] [Full Text] [Related]

  • 31. Utilization of spray drying technique for improvement of dissolution and anti-inflammatory effect of Meloxicam.
    Shazly G, Badran M, Zoheir K, Alomrani A.
    Pak J Pharm Sci; 2015 Jan 01; 28(1):103-11. PubMed ID: 25553688
    [Abstract] [Full Text] [Related]

  • 32. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.
    Bandarkar FS, Vavia PR.
    Drug Dev Ind Pharm; 2011 Nov 01; 37(11):1318-28. PubMed ID: 21506882
    [Abstract] [Full Text] [Related]

  • 33. Effect of excipients on dissolution enhancement of aceclofenac solid dispersions studied using response surface methodology: a technical note.
    Kumar S, Gupta SK.
    Arch Pharm Res; 2014 Mar 01; 37(3):340-51. PubMed ID: 23674128
    [Abstract] [Full Text] [Related]

  • 34. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
    Yousaf AM, Qadeer A, Raza SA, Chohan TA, Shahzad Y, Din FU, Khan IU, Hussain T, Alvi MN, Mahmood T.
    Polim Med; 2019 Mar 01; 49(1):35-43. PubMed ID: 31769938
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro determination of aceclofenac Mouth Dissolving Tablets.
    Shobhit S, Gupta SK.
    Polim Med; 2013 Mar 01; 43(4):227-9. PubMed ID: 24596037
    [Abstract] [Full Text] [Related]

  • 37. Piroxicam/2-hydroxypropyl-beta-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique.
    Zhang X, Wu D, Lai J, Lu Y, Yin Z, Wu W.
    J Pharm Sci; 2009 Feb 01; 98(2):665-75. PubMed ID: 18543294
    [Abstract] [Full Text] [Related]

  • 38. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
    Pralhad T, Rajendrakumar K.
    J Pharm Biomed Anal; 2004 Feb 04; 34(2):333-9. PubMed ID: 15013147
    [Abstract] [Full Text] [Related]

  • 39. Study of glimepiride-b-cyclodextrin complex.
    Moyano JR, Ventriglia T, Ginés JM, Muñoz F, Rabasco AM.
    Boll Chim Farm; 2003 Nov 04; 142(9):390-5. PubMed ID: 14971307
    [Abstract] [Full Text] [Related]

  • 40. Dissolution enhancement and formulation of rapid-release lornoxicam mini-tablets.
    Tawfeek HM, Saleem IY, Roberts M.
    J Pharm Sci; 2014 Aug 04; 103(8):2470-83. PubMed ID: 24995853
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.